17 employees
Meissa Vaccines is a pharmaceutical company focused on advancement of unmet vaccines against viruses that cause serious human diseases.
2014
$30M
from 2 investors over 2 rounds
Meissa Vaccines raised $30M on September 26, 2019
Investors: Morningside Venture Capital 晨兴资本 and MBX Capital